Literature DB >> 6530359

The EEG in progressive dialysis encephalopathy. The EEG and clinical indices of PDE in cases treated with desferrioxamine. (Part. II).

E Luda, C Canavese, G Rocca.   

Abstract

Two patients with progressive dialysis encephalopathy (PDE) were subjected to serial EEG recording and neuropsychological tests in order to assess the value of the investigations as indices of the course of PDE during desferrioxamine treatment. EEG proved unreliable for this purpose.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6530359     DOI： 10.1007/bf02042619

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  6 in total

1.  [Progressive myoclonic encephalopathy in dialysis patients. Clinical, electroencephalographic and neuropathological study. Pathogenetic discussion].

Authors:  O Sabouraud; M Chatel; F Menault; J Dien Peron; F Cartier; M Garre; J Gary; S Pecker
Journal:  Rev Neurol (Paris)       Date:  1978-10       Impact factor: 2.607

2.  Electroencephalographic criteria of hypocalcemia and hypercalcemia.

Authors:  M Swash; A J Rowan
Journal:  Arch Neurol       Date:  1972-03

3.  Low aluminium water, desferrioxamine, and dialysis encephalopathy.

Authors:  F J Milne; B Sharf; P D Bell; A M Meyers
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

4.  [Chronological study of signs of myoclonic encephalopathy in hemodialysis patients (author's transl)].

Authors:  M F Vecchierini-Blineau; H E Thebaud; L Dupouet; D Brochard; P Coville; J R Feve; P Guiheneuc
Journal:  Sem Hop       Date:  1981 Nov 18-25

5.  A new approach to the early detection of dialysis encephalopathy.

Authors:  J Barron; S J Whiteley; A C Horn; A R Ralston; P Ackrill
Journal:  Br J Disord Commun       Date:  1980-09

6.  Aluminum intoxication in dialysis patients.

Authors:  H Pogglitsch; C Knopp; O Wawschinek; W Petek
Journal:  Int J Artif Organs       Date:  1982-09       Impact factor: 1.595
  6 in total
  1 in total

1.  Advances in dialysis encephalopathy research: a review.

Authors:  Ying Chen; Xin Tian; Xuefeng Wang
Journal:  Neurol Sci       Date:  2018-05-02       Impact factor: 3.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.